Retropupillary Iris-Claw Intraocular Lens Implantation in Aphakia Post-Endophthalmitis
Downloads
Introduction: Endophthalmitis is a severe eye disease. Due to the previous condition, selecting the appropriate type of secondary intraocular lens (IOL) is challenging. The Objective of this report is to describe the outcome of retropupillary iris-claw intraocular lens (RP- ICIOL) implantation to treat aphakia in patients with low corneal endothelial cell count, lack of capsular support, and a history of endophthalmitis. Case Presentation: A 73-year-old female patient reported experiencing hazy vision in her right eye (RE) for four months following cataract surgery. The patient had previously been diagnosed with aphakia and endophthalmitis RE and was admitted for three days. The visual acuity of the RE was 1/60. On anterior segment examination, the cornea was clear, the anterior chamber was deep, there was no flare or cell, vitreous strands were present in the anterior chamber, and the pupil was irregular with an aphakic lens. Examination of the posterior segment was within normal limits. Specular microscopy showing corneal endothelial cell density (CECD) of RE was 1086 cells/mm2. The patient then underwent RP-ICIOL implantation. Post-operatively, the visual acuity of the RE improved to 6/25, and the intraocular pressure (IOP) was 11 mmHg, as measured using non-contact tonometry. Three months post-op, the visual acuity was 6/30, the IOP was 17 mmHg in the RE and the CECD was 1108 cells/mm2. Conclusions: Good and appropriate management of endophthalmitis can save a patient's vision. Secondary iris-claw IOL implantation is a viable treatment option for aphakia following endophthalmitis, offering the advantage of maintaining the physiologic posterior position and being minimally invasive.
Chen X, Xu J, Chen X, Yao K. Cataract: Advances in surgery and whether surgery remains the only treatment in future. Adv Ophthalmol Pract Res 2021;1:100008. https://doi.org/10.1016/j.aopr.2021.100008.
Lapp T, Wacker K, Heinz C, Maier P, Eberwein P, Reinhard T. Cataract surgery: Indications, techniques, and intraocular lens selection. Dtsch Arztebl Int 2023. https://doi.org/10.3238/arztebl.m2023.0028.
Jing W, Guanlu L, Qianyin Z, Shuyi L, Fengying H, Jian L, et al. Iris-claw intraocular lens and scleral-fixated posterior chamber intraocular lens implantations in correcting aphakia: A meta-analysis. Invest Ophthalmol Vis Sci 2017;58:3530. https://doi.org/10.1167/iovs.16-21226.
Yazdani-Abyaneh A, Djalilian AR, Fard MA. Iris fixation of posterior chamber intraocular lenses. J Cataract Refract Surg 2016;42:1707–1712. https://doi.org/10.1016/j.jcrs.2016.10.008.
Gontarz K, Dorecka M, Mrukwa-Kominek E. Secondary glaucoma associated with aphakia following complicated surgery for senile cataract: A review. Klin Oczna 2022;124:1–6. https://doi.org/10.5114/ko.2021.109973.
Kim SH, Yu MH, Lee JH, Kim SW, Rah SH. Endophthalmitis after cataract surgery in Korea: A nationwide study evaluating incidence and risk factors in a Korean population. Yonsei Med J 2019;60:467. https://doi.org/10.3349/ymj.2019.60.5.467.
Thanigasalam T, Reddy S, Zaki R. Factors associated with complications and postoperative visual outcomes of cataract surgery: A study of 1.632 cases. J Ophthalmic Vis Res 2015;10:375. https://doi.org/10.4103/2008-322X.158892.
Low L, Shah V, Norridge CFE, Donachie PHJ, Buchan JC. Royal college of ophthalmologists’ national ophthalmology database, report 10: Risk factors for post–cataract surgery endophthalmitis. Ophthalmology 2023;130:1228–1230. https://doi.org/10.1016/j.ophtha.2023.07.021.
Durand ML. Bacterial and Fungal Endophthalmitis. Clin Microbiol Rev 2017;30:597–613. https://doi.org/10.1128/CMR.00113-16.
Pappuru RR, Dave VP, Pathengay A, Gangakhedkar S, Sharma S, Narayanan R, et al. Endophthalmitis progressing to panophthalmitis: Clinical features, demographic profile, and factors predicting outcome. Semin Ophthalmol 2018;33:671–674. https://doi.org/10.1080/08820538.2017.1416411.
Verma L, Chakravarti A. Prevention and management of postoperative endophthalmitis: A case-based approach. Indian J Ophthalmol 2017;65:1396. https://doi.org/10.4103/ijo.IJO_1058_17.
Xu H, Fu B, Lu C, Xu L, Sun J. Successful treatment of endogenous endophthalmitis with extensive subretinal abscess: A case report. BMC Ophthalmol 2018;18:238. https://doi.org/10.1186/s12886-018-0908-x.
Vounotrypidis E, Schuster I, Mackert MJ, Kook D, Priglinger S, Wolf A. Secondary intraocular lens implantation: A large retrospective analysis. Graefes Arch Clin Exp Ophthalmol 2019;257:125–134. https://doi.org/10.1007/s00417-018-4178-3.
Sun J, Guo Z, Li H, Yang B, Wu X. Acute infectious endophthalmitis after cataract surgery: Epidemiological characteristics, risk factors and incidence trends, 2008–2019. Infect Drug Resist 2021;Volume 14:1231–1238. https://doi.org/10.2147/IDR.S304675.
Silpa-Archa S, Papirachnart A, Singhanetr P, Preble JM. Risk factors for endophthalmitis after cataract surgery in diabetic patients: A case control study. Int J Ophthalmol 2019;12:417–423. https://doi.org/10.18240/ijo.2019.03.11.
Randleman J, Ahmed I, editors. Intraocular Lens Surgery. 1st ed. New York: Thieme Medical Publisher; 2016.
Lundström M, Brege KG, Florén I, Lundh B, Stenevi U, Thorburn W. Postoperative aphakia in modern cataract surgery. J Cataract Refract Surg 2004;30:2111–2115. https://doi.org/10.1016/j.jcrs.2004.01.044.
Gurney NT, Al-Mohtaseb Z. Intraocular lens implantation in the absence of capsular support. Saudi J Ophthalmol 2022;36:157–162. https://doi.org/10.4103/sjopt.sjopt_186_21.
Shahid SM, Flores-Sánchez BC, Chan EW, Anguita R, Ahmed SN, Wickham L, et al. Scleral-fixated intraocular lens implants: Evolution of surgical techniques and future developments. Eye 2021;35:2930–2961. https://doi.org/10.1038/s41433-021-01571-5.
Liang I-C, Chang Y-H, Hernández Martínez AH, Hung C-F. Iris-claw intraocular lens: Anterior chamber or retropupillary implantation? A systematic review and meta-analysis. Medicina (B Aires) 2021;57:785. https://doi.org/10.3390/medicina57080785.
Copyright (c) 2025 Alvi Laili Zahra, Rizna Audina, Dini Dharmawidiarini, Sahata P. H. Napitupulu
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Vision Science and Eye Health Journal by Universitas Airlangga is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The journal allows the author to hold the copyright of the article without restrictions.
The journal allows the author(s) to retain publishing rights without restrictions.
The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Share-Alike (CC BY-SA).
The Creative Commons Attribution-Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violations.
